Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Anees Mussalam"'
Autor:
Ron Waksman, Anees Mussalam, J. James B. Edelman, Toby Rogers, Evan Shlofmitz, Deepakraj Gajanana, Rebecca Torguson, William S. Weintraub, Micaela Iantorno, Paul Kolm, Yuefeng Chen, Nausharwan Butt, Jaffar M. Khan, Nauman Khalid
Publikováno v:
Journal of the American College of Cardiology. 74:B420
Autor:
Paige Craig, Yuefeng Chen, Lowell F. Satler, Toby Rogers, Petros Okubagzi, James Edelman, Itsik Ben-Dor, Michael Fuery, Nauman Khalid, Cheng Zhang, Jaffar M. Khan, Anees Mussalam, Evan Shlofmitz, Ron Waksman, Rebecca Torguson
Publikováno v:
Journal of the American College of Cardiology. 74:B667
Iatrogenic coronary obstruction remains a devastating complication of transcatheter aortic valve replacement (TAVR). Recent studies demonstrated that a valve-to-coronary distance (VTC)
Autor:
Evan Shlofmitz, Hector M. Garcia-Garcia, Toby Rogers, Ron Waksman, Itsik Ben-Dor, Cheng Zhang, Nelson L. Bernardo, Yuefeng Chen, Lowell F. Satler, Rebecca Torguson, Hayder Hashim, Aaphtaab Dheendsa, Nauman Khalid, Anees Mussalam
Publikováno v:
Journal of the American College of Cardiology. 74:B53
Autor:
Ron Waksman, James M. Edelman, Evan Shlofmitz, Rebecca Torguson, Federico M. Asch, Quan Zou, Paige Craig, Toby Rogers, Anees Mussalam, Nauman Khalid, Diego Medvedofsky, Yuefeng M. Chen, Jaffar M. Khan, Gaby Weissman
Publikováno v:
JACC: Cardiovascular Interventions. 12:S44
The Low Risk TAVR trial was the first FDA-approved trial of transcatheter aortic valve replacement (TAVR) in low-surgical-risk patients in the United States. 14% developed hypoattenuated leaflet thrombosis (HALT) on 30-day computerized tomography (CT
Autor:
James Edelman, Paige Craig, Caroline Barnes, Vinod H. Thourani, Toby Rogers, Lowell F. Satler, Ron Waksman, Anees Mussalam, Rebecca Torguson, Yuefeng M. Chen, Evan Shlofmitz, Jaffar M. Khan, Nauman Khalid
Publikováno v:
JACC: Cardiovascular Interventions. 12:S55
Mitral valve disease is the most common valve pathology, but patients are not good surgical candidates. Novel transcatheter repair and replacement options are available in clinical trials. However, many patients are not referred for treatment. When r